The Koch Institute’s Annual Symposium highlights emerging successes and challenges in the advancement of vaccines to prevent and treat cancer.

In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.

SMART researchers find the enzyne RlmN, which directly senses chemical and environmental stresses, can be targeted in drug development.

Cambridge scientists have identified a signature in the blood that could help predict how well an individual will respond to vaccines. The discovery, published

MIT researchers characterize gene expression patterns for 22,500 brain vascular cells across 428 donors, revealing insights for Alzheimer’s onset and potential treatments.

Aided by machine learning, scientists are working to develop a vaccine that would be effective against all SARS-Cov-2 strains.

A new study reveals that lymph nodes near the lungs create an environment that weakens T-cell responses to tumors.

The new bivalent boosters against COVID-19 have failed to halt omicron infections. However, new technologies are being developed that pave a way forward.

An overactive immune response to infection can be deadly. Studying how one key player called tumor necrosis factor, or TNF, induces lethal immune responses could provide new treatment targets.